Clinical trial for Eosinophilic Esophagitis (EoE)
Official title Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis
ClinicalTrials.gov ID: NCT07234825
What this study is testing
- What it's testing
- The study wants to see if this diet helps achieve remission and how it changes immune function, gut bacteria, and exposure to environmental toxins.
- Who it's for
- People who have been diagnosed with eosinophilic esophagitis.
- What's involved
- Participants will follow a partial enteral nutrition plan while avoiding dairy, and will have regular visits and tests to monitor their condition.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 21
You may be able to join if
- Pediatric patients 1 year to 21 of age presenting with chronic symptoms of dysphagia, odynophagia, vomiting or heartburn, chronic abdominal pain...
You likely can't join if
- Non-English-Speaking people, adults unable to consent, wards of the state, pregnant women, and prisoners will be excluded from the study.
- Patients with autoimmune conditions such as inflammatory bowel disease. Patients with prior esophageal or intestinal surgeries.
- Patients with history of eating disorders or ARFID.
- Patients with fistulizing or fibrotic disease on baseline EGD.
- Patients who have received proton pump inhibitory therapy in the past month.
The study team makes the final eligibility decision.
Where it is enrolling
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Seattle, Washington, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.